laboratori corp america hold
laboratori corp america hold || north
new thing learn
lh share intra-day elev expect
print step back trend support invest
thesi lt share gain opportun stabl price take
margin declin slow rais price target
laboratori corp america
stabl manag care contract share shift underscor volum gain
come region player net manag care contract chang repres
bp headwind stabl trend compar headwind
bp in-lin expect sequenti bp loss smaller
sequenti bp gain quest report earlier week see
highlight volum like come expens region player
manag expect trend remain stabl remaind year
separ volum headwind bp higher
expect repres primari main sourc headwind report
volum guidanc call dtc volum flat remaind
year
price trend improv price disciplin continu key
lab sustain current premium valuat trend report quarter
suggest stabl improv environ specif normal pama
rate cut divestitur despit addit new capit contract
price quarter versu note
improv may due rel slowdown
launchpad save show margin lab adjust oper margin
came bp higher estim bp y/i declin
bp sequenti improv compar bp y/i declin
bp sequenti improv showcas benefit labcorp cost
save initi importantli manag expect margin
deterior deceler versu launchpad initi gain
laboratori corp america hold lh na
 distribut unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
steam
increas enthusiasm prefer lab network pln
contribut ceo david king sound increment posit
potenti benefit pln base initi unit
take discuss overal uptak pln
depend physician patient incent put place
continu look color incent year progress note
start august provid refer member out-of-network
lab subject on-line approv process think administr
hurdl like de-incentiv provid util region lab
steer volum pln simpli way avoid extra paperwork
potenti exclus manag care contract open
manag re-affirmed thesi shift high qualiti low cost
provid repres opportun contract open though
like alway appetit exclus region contract certain
geographi base patient concentr florida contract
current exclus quest exampl contract compani
opportun open exhibit list bcb contract
rais price target previous bull case
previous bear case previous updat dcf base
price target factor higher beta vs previous higher
equiti risk premium vs previous lower risk free rate
base case dcf includ termin growth wacc
impli price-to-earnings bull case ep
impli price-to-earnings bull case ep
covanc top-lin growth higher termin growth rate
impli price-to-earnings base case ep
impli price-to-earnings base case ep
revenu growth mid-term growth
covanc top-lin growth normal follow integr chiltern
acquisit termin growth rate
impli bear case ep
impli bear case ep
lab util slow manag care contract re-contract base pama
chiltern acquisit underperform covanc struggl see top-lin
growth termin growth rate
labcorp second largest refer lab
compani matur industri
plan open lab contract
establish long-term strateg partnership
labcorp quest diagnost
set stage ration price share
gain opportun posit lab
rel safe haven within hc servic
headwind reimburs
pressur exposur quantifi
factor ms/market expect
diversifi labcorp busi faster
strateg partnership larg pharma
acquisit lcd cdd
risk achiev price
reimburs pressur may greater
expect
covanc chiltern deal synergi
neg pama impact commerci
exhibit labcorp vs quest in-network lab comparison bcb plan januari
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report ricki
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
